Actually Getting Help
HRT, non-hormonal options, how to find a provider who listens, and how to advocate for yourself in a system that still, too often, says "it's just aging." It's not. And you have options.
Let's talk about HRT — honestly
Hormone Replacement Therapy (also called Menopausal Hormone Therapy or MHT) has had a complicated reputation for decades — mostly because of a 2002 Women's Health Initiative study that was widely misinterpreted and applied to the wrong population.
The current evidence is clear: for women in the perimenopausal window — particularly those under 60 and within 10 years of their last period — the benefits of HRT significantly outweigh the risks. In 2025, the FDA removed the Black Box warning from HRT prescribing information, reflecting the evolution of evidence since 2002.
Myths vs. what the research actually says
The fear around HRT has kept millions of women from effective treatment. Here's where the evidence actually stands.
"HRT causes breast cancer."
The risk — if any — is very small, associated specifically with combined oral therapy used long-term. It's comparable to the risk from drinking one glass of wine per day. Transdermal estrogen at low doses has a significantly more favorable profile.
"You shouldn't start HRT if you're still having periods."
Perimenopause is often when HRT is most beneficial. The "timing hypothesis" supports starting earlier in the transition window for the strongest long-term benefit.
"If your symptoms aren't severe, you don't need treatment."
Symptom severity is one factor — but estrogen also plays a protective role in bone density, cardiovascular health, and cognitive function. Treatment decisions should factor in the full picture.
"Bioidentical hormones are safer than pharmaceutical HRT."
Compounded "bioidentical" hormones are not regulated for consistency or safety. FDA-approved transdermal options use the same molecular structure as the body's own hormones and have a robust evidence base.
How to advocate for yourself in a doctor's office
Women are dismissed at an extraordinary rate when seeking perimenopause care. These questions — grounded in current clinical guidelines — can help you have a more productive conversation.
- "I'd like to discuss hormone therapy as an option. Can we review whether I'm a candidate based on current guidelines?"
- "Are you familiar with the 2023 Practitioner's Toolkit for Managing Menopause from the International Menopause Society?"
- "Can we discuss transdermal estrogen specifically — I've read it has a different risk profile than oral therapy."
- "I'm concerned these symptoms are affecting my quality of life and work. Can we look at all treatment options?"
- "If you don't specialize in menopause medicine, can you refer me to someone who does?"
What the science actually says
Current evidence on HRT safety, efficacy, and clinical guidelines — updated 2023–2025.
Menopausal Hormone Therapy — Risks, Benefits and Emerging Options
Comprehensive review of MHT across benefit and risk domains — cardiovascular, bone, cognitive, and cancer. Reflects the most up-to-date understanding of how timing, route, and dose affect the benefit-risk calculation.
Read the study →The 2025 Menopausal Hormone Therapy Guidelines
One of the most recent comprehensive clinical guidelines on MHT, synthesizing global evidence on indications, contraindications, dosing, and monitoring. Reflects current international consensus.
Read the guidelines →Reconsidering Hormone Replacement Therapy: Current Insights on Utilisation
Addresses the historic underutilization of HRT following the 2002 WHI misinterpretation and documents the shift toward more individualized, evidence-based prescribing.
Read the study →New FDA Guidance on Hormone Replacement Therapy: How Updated Labels Could Change Menopause Treatment
Covers the FDA's 2025 decision to remove the Black Box warning from HRT prescribing information — a significant shift reflecting evolving evidence on safety.
Read the update →The 2023 Practitioner's Toolkit for Managing Menopause
The most widely referenced clinical toolkit for menopause management. Know it exists — it's what a well-trained provider should be working from, and a useful reference in any appointment.
Read the toolkit →